<DOC>
	<DOCNO>NCT00841386</DOCNO>
	<brief_summary>The purpose study determine effectiveness collagen cross-linking cornea halt progression possibly partially reverse effect keratoconus . Keratoconus progressive weakening cornea cause irregular astigmatism thin cornea . The overall effect reduction vision , advanced case , scar cornea may lead need corneal transplantation . Cross-linking show increase rigidity cornea . The patient would treat follow 24 month . .</brief_summary>
	<brief_title>Treatment Keratoconus Using Collagen Cross-Linking</brief_title>
	<detailed_description>The goal two group approximately 66 patient include study . One eye first group undergo treatment , second group age match individual serve control . It prospective , randomize , blind study . Each patient randomize begin enrollment study receive randomization number . The follow parameter follow : 1 . Best correct spectacle acuity ( BCSA ) 2 . The steep keratometry measurement ( KMax ) measure computerized corneal topography 3 . Apical corneal thickness 4 . Corneal mechanical resistance . These measurement repeat 1 month , 3 month , 6 month , 12 , 18 , 24 month follow treatment .</detailed_description>
	<mesh_term>Keratoconus</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<mesh_term>Flavin Mononucleotide</mesh_term>
	<criteria>prior history ocular surgery treatment eye must maximum corneal power 47 D 60 diopter corneal thickness must great 400 µ absence corneal scar patient must meet diagnostic criterion keratoconus , include one follow feature : high myopia corneal ectasia view slitlamp exam measure pachometry Vogt 's stria topographic finding superior flatten inferior steepen cornea presence Fleischer ring history prior ocular surgery ( history contact lens use exclusion criterion ) average corneal power &gt; 60 D presence corneal scar corneal thickness 400 µ less history herpes simplex virus keratitis history uveitis preexist glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Cornea</keyword>
	<keyword>Keratoconus</keyword>
	<keyword>Ectasia</keyword>
	<keyword>Riboflavin</keyword>
	<keyword>Collagen cross-linking</keyword>
</DOC>